Reposted by Edward Nirenberg
BPZE1 was well tolerated in kids 6-17, triggered strong nasal S-IgA to B pertussis, didn’t affect Tdap's serum IgG responses. Supports BPZE1 for 6+ y/o. 🧒💉✨
thelancet.com
[Articles] Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6–17 years: a randomised, active-controlled and placebo-controlled, phase 2b trial
BPZE1 was well tolerated in children aged 6–17 years, and induced robust nasal S-IgA responses to B pertussis WCE without interference from simultaneously administered Tdap. BPZE1 vaccination did not interfere with Tdap-induced serum IgG to B pertussis antigens and tetanus and diphtheria toxoids. These findings support further development of BPZE1 as a vaccine candidate against pertussis in acellular pertussis vaccine-primed children 6 years and older.